Pirarubicin
From Self-sufficiency
File:Pirarubicin.png | |
Systematic (IUPAC) name | |
---|---|
(3S)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-α-L-lyxo-hexopyranoside | |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | 72496-41-4 |
ATC code | L01DB08 (WHO) |
PubChem | CID 3033521 |
Synonyms | (9S)-7-[(2R,4S,5S,6S)-4-amino-6-methyl-5-[(2R)-oxan-2-yl]oxyoxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione |
Chemical data | |
Formula | C32H37NO12 |
Molar mass | 627.63 g/mol[[Script error: No such module "String".]] |
Script error: No such module "collapsible list". |
Pirarubicin (INN) is an anthracycline drug.
40px | This antineoplastic or immunomodulatory drug article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Drugs with non-standard legal status
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- 2Fix
- Anthracyclines
- Antineoplastic drugs
- Tetrahydropyrans
- Phenols
- Phenol ethers
- Antineoplastic and immunomodulating drug stubs